Study of Intradermal Injections of RCS-01 in Male and Female Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02391935 |
|
Recruitment Status :
Completed
First Posted : March 18, 2015
Last Update Posted : October 11, 2017
|
Sponsor:
RepliCel Life Sciences, Inc.
Collaborators:
JensonR+ Limited
PHARMALOG Institut für klinische Forschung GmbH
Syreon Corporation
Innovacell Biotechnologie AG
Datinf GmbH
Information provided by (Responsible Party):
RepliCel Life Sciences, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 12, 2017 |
| Actual Study Completion Date : | July 12, 2017 |